LeMaitre Vascular Inc
$ 92.34
0.00%
11 Jun - close price
- Market Cap 2,110,037,000 USD
- Current Price $ 92.34
- High / Low $ 93.08 / 90.87
- Stock P/E 33.95
- Book Value 17.80
- EPS 2.72
- Next Earning Report 2026-08-10
- Dividend Per Share $0.85
- Dividend Yield 0.92 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.17 %
- 52 Week High 117.72
- 52 Week Low 78.29
About
LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
Analyst Target Price
$118.75
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-25 | 2025-11-06 | 2025-08-05 | 2025-05-01 | 2025-02-27 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-27 | 2023-11-01 | 2023-08-01 |
| Reported EPS | 0.68 | 0.68 | 0.75 | 0.6 | 0.48 | 0.49 | 0.49 | 0.52 | 0.44 | 0.38 | 0.33 | 0.37 |
| Estimated EPS | 0.66 | 0.66 | 0.56 | 0.57 | 0.5 | 0.49 | 0.43 | 0.47 | 0.39 | 0.36 | 0.3 | 0.32 |
| Surprise | 0.02 | 0.02 | 0.19 | 0.03 | -0.02 | 0 | 0.06 | 0.05 | 0.05 | 0.02 | 0.03 | 0.05 |
| Surprise Percentage | 3.0303% | 3.0303% | 33.9286% | 5.2632% | -4% | 0% | 13.9535% | 10.6383% | 12.8205% | 5.5556% | 10% | 15.625% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-10 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.81 |
| Currency | USD |
Previous Dividend Records
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | May 2025 | Jan 1970 | Mar 2025 | Dec 2024 | Aug 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-06-04 | 2026-03-26 | 2025-12-04 | 2025-09-04 | 2025-05-29 | None | 2025-03-27 | 2024-12-05 | 2024-08-29 | 2024-05-30 |
| Amount | $0.25 | $0.25 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.16 | $0.16 | $0.16 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LMAT
2026-06-11 17:11:01
LeMaitre Vascular, Inc. (LMAT) has declared a quarterly cash dividend of $0.25 per share. This dividend is payable on August 29, 2024, to stockholders of record as of August 15, 2024. The announcement signifies a return to shareholders and indicates the company's financial health.
2026-06-11 07:10:09
LeMaitre Vascular (NASDAQ:LMAT) shares recently crossed above their 200-day moving average, reaching $97.83 before settling at $92.34. The company maintains a "Moderate Buy" consensus rating with an average analyst price target of $112.60, following several analyst upgrades. Despite positive earnings and dividend announcements, there has been significant insider selling, while institutional investors continue to hold the majority of the stock.
2026-06-06 04:10:07
LeMaitre Vascular director Joseph P. Pellegrino Jr. was granted several Dividend Equivalent Rights awards on June 4, 2026, tied to existing equity awards. These rights, which are the economic equivalent of one share of LeMaitre Vascular common stock, vest proportionately with their underlying restricted stock unit and performance share unit awards from prior grant dates. These transactions are considered routine compensation accruals, not open-market stock trades.
2026-06-05 21:40:25
This article details an insider trading activity for LEMAITRE VASCULAR INC (LMAT) as reported in a Form 4 filing. Director Martha Shadan received compensation-related awards of dividend equivalent rights tied to prior equity grants, acquiring five derivative positions on June 4, 2026. These rights are economically equivalent to one share of common stock each, with no exercise price, and will vest alongside the underlying restricted stock unit and performance share unit awards granted between 2023 and 2025.
2026-06-05 21:40:25
LeMaitre Vascular director Lawrence J. Jasinski has received grants of dividend equivalent rights tied to his existing equity awards, specifically restricted stock unit and performance share unit awards from 2023, 2024, and 2025. These rights are compensation-related accruals and do not involve open-market buying or selling of shares. Each dividend equivalent right mirrors the economic value of one share of LeMaitre Vascular common stock and vests proportionally with the underlying awards.
2026-06-05 21:40:25
LeMaitre Vascular director John James O’Connor was granted dividend equivalent rights on June 4, 2026, as routine compensation tied to existing restricted stock unit and performance share unit awards. These rights, each economically equivalent to one share of LMAT common stock, accrue at a price of $0.00 and vest proportionately with the underlying awards from 2023, 2024, and 2025. Following these transactions, O’Connor directly holds 5.0674 dividend equivalent rights, reflecting equity-based compensation rather than open-market trading.
